Learn more about Cabergoline. User Ratings 10 46 (11) 9 9 (2) 8 25 (6) 7 5 (1) 6Home Conditions Hyperprolactinemia Cabergoline Print Also known as: Dostinex The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful.
Bestsellers Erectile Dysfunction ED Sets Allergies Anti Fungal. Anti Viral Antibiotics Anxiety Arthritis Asthma Birth Control. Blood Pressure Cholesterol Lowering Depression Diabetes Gastrointestinal. Hair Loss Heart Disease Herbals Man s Health Muscle Relaxant.
The side effects listed below are not experienced by everyone who takes this medication. If you are concerned about side effects, discuss the risks and benefits of this medication with your doctor.Tenants include Harris Teeter, Talbots, Stein Mart, Office Depot, Pier One, Books-A-Million, Rite Aid.
Cabergoline (brand names Caberlin, Dostinex and Cabaser an ergot derivative, is a potent dopamine receptor agonist on D 2 receptors. Rat studies show cabergoline).Name of Drug Cabergoline Tablets : We supply Cabgolin manufactured by SUN Pharmaceuticals. (Cabgolin is also known as Caberlin manufactured by Sun.
Stimulating dopamine receptors reduces the production of the pituitary hormone prolactin, reduces the levels of growth hormone in people with acromegaly, and improves symptoms of Parkinson s. The FDA approved bromocriptine on June 28, 1978.Your doctor may start you on 0.375 mg and adjust your.
12 3 acid. 4 .
Drugs Medications COMMON BRAND NAME (S Dostinex GENERIC NAME (S CABERGOLINE I want to save to My Medicine. YES Uses This medication is used to treat high levels of prolactin hormone in your body. Keep all medicines away from children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed.
Does cabergoline interact with other medications? Should I avoid certain foods while taking cabergoline? Overdose If overdose is suspected, contact a poison control center or emergency room right away. US residents can call their local poison control center at.
SIDE EFFECTS The safety of DOSTINEX Tablets has been evaluated in more than 900 patients with hyperprolactinemic disorders. Most adverse events were mild or moderate in severity. In a 4-week, double-blind, placebo-controlled study, treatment consisted of placebo or cabergoline at fixed doses of 0.125, 0.5.
Fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at. List cabergoline side effects by likelihood and severity. Precautions Before taking cabergoline, tell your doctor or pharmacist if you are allergic to it;.
Max: 1mg twice weekly. Children: Not recommended. Contraindications: Uncontrolled hypertension. Sensitivity to ergot alkaloids. Warnings/Precautions: Not for pregnancy-induced hypertension or postpartum lactation inhibition or suppression. Respiratory or cardiac disease due to fibrosis.
Get medical help right away if you have any serious side effects, including: chest pain, lower back/flank pain, change in the amount of urine. A very serious allergic reaction to this drug is rare.
A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
Do not start, stop, or change the dosage of any medicines without your doctor's approval. Some products that may interact with this drug include: antipsychotic medications (such as chlorpromazine, haloperidol, thiothixene lorcaserin, metoclopramide, prochlorperazine.
Tell your doctor if your condition persists or worsens. What conditions does cabergoline treat? Side Effects. Nausea, vomiting, stomach upset, constipation, dizziness, lightheadedness, or tiredness may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Incidence of Reported Adverse Events During the 4-Week, Double-Blind, Placebo- Controlled Trial Adverse Event. Cabergoline (n168) 0.125 to 1 mg two times a week Placebo (n20) Number (percent) Gastrointestinal Nausea 45 (27) 4 (20) Constipation 16 (10) 0.